Zobrazeno 1 - 10
of 22
pro vyhledávání: '"D. F. Chiuten"'
Autor:
David T. Carr, D. F. Chiuten, Calvin L. Dixon, Manuel Valdivieso, Daniel J. Booser, Dhingra Hm, Peter Farha, T. Umsawasdi, H. Thomas Barkley, William K. Murphy, Gary Spitzer
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 11:511-519
Esophageal complications from combined chemoradiotherapy (CCRT) were analyzed in 55 patients with limited non-small cell lung cancer. CCRT consisted of chemotherapy (cyclophosphamide, doxorubicin (Adriamycin), and cisplatin: CAP) and chest irradiatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee649539c4219db4dd1ca43e1f00ed6b
https://doi.org/10.1016/0360-3016(85)90182-8
https://doi.org/10.1016/0360-3016(85)90182-8
Autor:
William K. Murphy, Manuel Valdivieso, H. Thomas Barkley, Peter Farha, Dhingra Hm, D. F. Chiuten, David T. Carr, T. Umsawasdi, Calvin L. Dixon, Michael S. Ewer, Daniel J. Booser, Bruce Mackay, Gary Spitzer
Publikováno v:
Cancer. 64:1995-2000
A prospective randomized study was done to determine the effect of different doxorubicin (Adriamycin [ADR], Adria Laboratories, Columbus, OH) administration (schedules every week versus every 3 weeks) on the productivity of a cyclophosphamide, ADR, c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f503bff589445b6aac7f8aa7e6ac989c
https://doi.org/10.1002/1097-0142(19891115)64:10<1995::aid-cncr2820641004>3.0.co
https://doi.org/10.1002/1097-0142(19891115)64:10<1995::aid-cncr2820641004>3.0.co
Autor:
D. F. Chiuten, Agop Y. Bedikian, John A. Benvenuto, Gerald P. Bodey, Manuel Valdivieso, Benjamin Drewinko
Publikováno v:
American Journal of Clinical Oncology. 9:129-131
Twenty-three patients with a variety of solid tumors were given thymidine (dThd) at a single dose of 30 g/m2 along with cisplatin (DDP) at escalating doses ranging from 25 to 120 mg/m2. The dThd was administered first, and then after 50% of the total
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82360a593b05201937b796498ddeb074
https://doi.org/10.1097/00000421-198604000-00005
https://doi.org/10.1097/00000421-198604000-00005
Autor:
Ti Li Loo, A.A. Miller, Agop Y. Bedikian, Emil J. Freireich, Manuel Valdivieso, D. F. Chiuten, John A. Benvenuto, G. P. Bodey
Publikováno v:
American journal of clinical oncology. 8(4)
Twenty-seven patients with colorectal adenocarcinoma, (12) non-small cell bronchogenic carcinoma, (11) gastric adenocarcinoma (3), and adenocarcinoma of unknown primary lesion (1) were treated with the combination of thymidine (TdR), 5-fluorouracil (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a8fe78516080c41867ab30eb2527586
https://pubmed.ncbi.nlm.nih.gov/4083263
https://pubmed.ncbi.nlm.nih.gov/4083263
Autor:
D F, Chiuten, J M, Bennett, R H, Creech, J, Glick, G, Falkson, H S, Brodovsky, C B, Begg, F M, Muggia, P P, Carbone
Publikováno v:
Cancer treatment reports. 63(1)
Thirty-six patients with stage III and IV Hodgkin's disease and non-Hodgkin's lymphoma, who had become refractory to conventional chemotherapy, were treated with VM-26. Complete remissions were documented in two patients with diffuse histiocytic lymp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::436a1b3a48f2045bdc52f2fd4b99d479
https://pubmed.ncbi.nlm.nih.gov/369693
https://pubmed.ncbi.nlm.nih.gov/369693
Autor:
H M, Dhingra, M, Valdivieso, D J, Booser, T, Umsawasdi, D T, Carr, D F, Chiuten, W K, Murphy, B F, Issell, G, Spitzer, P, Farha
Publikováno v:
Cancer treatment reports. 68(4)
Forty-one patients with unselected advanced non-small cell lung cancer were treated with a combination of etoposide and cisplatin. A response rate of 19%, a 78-week median survival of responders, and a 36-week overall median survival were observed.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a700702992a2e782a0a6b584f079c023
https://pubmed.ncbi.nlm.nih.gov/6538811
https://pubmed.ncbi.nlm.nih.gov/6538811
Publikováno v:
Cancer research. 39(10)
4'-(9-Acridinylamino)methanesulfon-m-anisidide (m-AMSA, NSC 249992), an acridine derivative, was given to 28 patients with solid tumors and one patient with Hodgkin's disease in a Phase I clinical trial. The dose schedule used was a single dose given
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7f70d214b63fad8cb6995c5b487c372e
https://pubmed.ncbi.nlm.nih.gov/476624
https://pubmed.ncbi.nlm.nih.gov/476624
Autor:
D F, Chiuten, D T, Carr, H M, Dhingra, W K, Murphy, G, Spitzer, T, Umsawasdi, G P, Bodey, M, Valdivieso
Publikováno v:
Cancer treatment reports. 70(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ca68c9510eb12b892b8bbde465a3ccac
https://pubmed.ncbi.nlm.nih.gov/3015403
https://pubmed.ncbi.nlm.nih.gov/3015403
Autor:
D F, Chiuten, G J, Vosika, M T, Shaw, M, Boiron, C, Gisselbrecht, M, Marty, G, Higgins, F M, Muggia
Publikováno v:
Anticancer research. 1(2)
All Phase II studies with diglycoaldehyde with leukemia and solid tumors have been reviewed. The dose schedules employed ranged from 1.5 to 2.0 g/m2/day for 3 to 5 days. The most common side effects have been gastrointestinal (nausea and vomiting), w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e748551c55843d631b6f86a7ccdecb51
https://pubmed.ncbi.nlm.nih.gov/7347155
https://pubmed.ncbi.nlm.nih.gov/7347155
Autor:
F, Laberge, H A, Fritsche, T, Umsawasdi, D T, Carr, S, Welch, W K, Murphy, D F, Chiuten, H M, Dhingra, P, Farha, G, Spitzer
Publikováno v:
Cancer. 59(12)
Carcinoembryonic antigen (CEA) was measured in 147 patients at diagnosis of small cell lung cancer; 17% of patients with limited disease and 51% with extensive disease had an abnormal CEA level (greater than 10 ng/ml). The median level was higher in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e4b199ecddbf7c69948760899b4472db
https://pubmed.ncbi.nlm.nih.gov/3032400
https://pubmed.ncbi.nlm.nih.gov/3032400